Early Pathogenesis of Cystic Fibrosis Related Diabetes
Early Pathogenesis of Cystic Fibrosis Related Diabetes
批准号:
10397094
负责人:
JOHN F ENGELHARDT
金额:
$147.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-30 至 2024-03-31
关键词:
6 year oldATAC-seqAcinar CellAdolescentAdultAffectAgeAnimal ModelB-LymphocytesBiologyBirthCaucasiansCellsCharacteristicsChildChloride ChannelsChromatinComplicationCystic FibrosisDataDefectDevelopmentDevelopmental BiologyDiabetes MellitusDiseaseDissectionDuct (organ) structureDuctal Epithelial CellDuctal EpitheliumEndocrineEnvironmental Risk FactorEpigenetic ProcessEventExocrine pancreasFerretsFibrocystic Disease of PancreasFunctional disorderGallbladderGenetic EngineeringGenetic TranscriptionGlucoseGoalsHormonesHumanHyperglycemiaIn VitroInflammatoryInjuryInstitutionInsulin-Dependent Diabetes MellitusInternal Ribosome Entry SiteIntestinesKnowledgeLifeLinkLiverLungMaintenanceMapsMediatingModelingMorbidity - disease rateMusNatural regenerationNeonatalNon-Insulin-Dependent Diabetes MellitusNutritionalOnset of illnessOutcomePancreasPancreatic DiseasesPancreatic InjuryPancreatic ductPancreatitisPathogenesisPathway interactionsPatientsPatternPharmacologyPhasePhenotypePhysiologyPopulationPrevention strategyPreventive treatmentProcessPropertyRecoveryReporterReportingResearchResourcesSeveritiesSourceTGFB1 geneTestingTherapeuticTranslatingVX-770Withdrawalage relatedbaseclinical carecomorbiditycystic fibrosis patientscystic fibrosis related diabetesdevelopmental diseaseendocrine pancreas developmentfetalgenetic manipulationglycemic controlin uteroin vitro Modelin vivoinsulin secretionisletislet stem cellslung healthmortalitynovelpostnatalpostnatal periodprogenitorprogramspulmonary functionstem cellstooltranscriptome sequencing
中文摘要
1项目概要
2囊性纤维化(CF)是高加索人群中最常见的致死性常染色体隐性遗传疾病,
3由囊性纤维化传导调节因子(CFTR)氯离子通道缺陷引起。CF是多器官
4.影响肺、胰、肝、肠和胆的疾病。囊性纤维化相关糖尿病(CFRD)是
5是CF最常见的严重并发症,并与发病率和死亡率增加相关。面板堆石坝,
6,其在病理生理学上不同于1型和2型糖尿病,显著增加了营养和
7 CF患者的肺部健康。我们对CF雪貂和3个月至6岁儿童的研究表明,
CFRD的基础发生在生命早期,此时腺泡细胞丢失,炎症/纤维化重塑
9发生。在CF雪貂中,这种外分泌驱动的胰腺重塑导致了由b细胞丢失引起的血糖危机
10和/或功能障碍。有趣的是,CF雪貂中新形成的b细胞的出现与一种短暂的
11例血糖控制恢复。尽管如此,那些早期血糖紊乱最严重的CF雪貂
12在以后的生活中发展CFRD。我们还报道了类似的血糖紊乱模式,
13 CF幼儿会出现康复。我们的中心假设是CF雪貂胰腺中的新b细胞
14来源于外分泌祖细胞和/或定向去分化的B细胞。三血统追踪雪貂
将使用15个模型对b细胞祖细胞(INS-IRES-CreERT2)、导管来源的内分泌祖细胞
16(KRT7-IRES-CreERT2)和腺泡来源的内分泌祖细胞(PTF1A-IRES-CreERT2)。使用附加
17 CFTRG551D雪貂模型,其使用CFTR调节剂提供胰腺疾病发作的时间控制
VX-770,将允许解剖胰腺炎的发育时间如何影响祖细胞状态
19和混凝土面板堆石坝的长期发展。我们在体内和体外的初步数据也表明,CF雪貂导管,
20细胞获得与胰腺祖细胞中发现的转录和表观遗传状态一致的特性
21发展中这种改变的机制将通过使用体外模型和本研究进行研究。
图22显示CF雪貂胰腺在子宫内发育期间胰腺祖细胞的特化。拟议
23项研究汇集了两个在CF胰腺疾病动物模型方面具有专业知识的机构,
24胰岛内分泌前体细胞的谱系追踪,以及面板堆石坝的综合生理学,
25胰岛复苏CF使用有史以来第一次非啮齿动物谱系追踪模型。这些研究预计将
26确定不仅与CFRD相关的机制,而且还与其他形式的胰源性糖尿病相关。
英文摘要
1 Project Summary
2 Cystic Fibrosis (CF) is the most common lethal autosomal recessive disorder in Caucasian populations and is
3 caused by defects in the cystic fibrosis conductance regulator (CFTR) chloride channel. CF is a multi-organ
4 disease affecting the lung, pancreas, liver, intestine, and gallbladder. Cystic fibrosis related diabetes (CFRD) is
5 the most common severe complication of CF and is associated with increased morbidity and mortality. CFRD,
6 which is pathophysiologically distinct from type 1 and type 2 diabetes, significantly worsens the nutritional and
7 pulmonary health of CF patients. Our studies in CF ferrets and children 3 months to 6 years of age suggest that
8 the underpinnings of CFRD occur very early in life when acinar cells are lost and inflammatory/fibrotic remodeling
9 occurs. In CF ferrets, this exocrine-driven pancreatic remodeling leads to a glycemic crisis caused by b-cell loss
10 and/or dysfunction. Interestingly, the emergence of newly formed b-cells in CF ferrets coincides with a transient
11 recovery in glycemic control. Nonetheless, those CF ferrets with the greatest early-life glycemic disturbances go
12 on to develop CFRD later in life. We have also reported that a similar pattern of glycemic disturbance and
13 recovery occurs in young CF children. Our central hypothesis proposes that new b-cells in the CF ferret pancreas
14 are derived from exocrine progenitors and/or committed dedifferentiated b-cells. Three lineage tracing ferret
15 models will be used to fate map b-cell progenitors (INS-IRES-CreERT2), ductal-derived endocrine progenitors
16 (KRT7-IRES-CreERT2), and acinar-derived endocrine progenitors (PTF1A-IRES-CreERT2). The use of an additional
17 CFTRG551D ferret model, which affords temporal control of pancreatic disease onset using the CFTR modulator
18 VX-770, will allow for dissection of how the developmental timing of pancreatitis impact progenitor cell states
19 and longer-term progression of CFRD. Our in vivo and in vitro preliminary data also show that CF ferret ductal
20 cells acquire properties consistent with the transcriptional and epigenetic states found in pancreatic progenitors
21 during development. The mechanisms of this alteration will be investigated by using in vitro models and the study
22 of pancreatic progenitor cell specification during in utero development of the CF ferret pancreas. The proposed
23 research has brought together two institutions with expertise in animal modeling of CF pancreatic disease,
24 lineage-tracing of islet endocrine precursors, and integrated physiology of CFRD to delineate the mechanism of
25 islet resurgence in CF using the first ever non-rodent lineage-tracing models. These studies are expected to
26 identify mechanisms not only relevant to CFRD, but also other forms of pancreatogenic diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of Submucosal Gland Stem Cells in the Airway
-
批准号:10516449
-
项目类别:
-
资助金额:$74.51万
-
财政年份:2022
-
负责人:JOHN F ENGELHARDT
-
依托单位:
National Ferret Research and Resource Institute (NFRRI) at University of Iowa
-
批准号:10596901
-
项目类别:
-
资助金额:$797.5万
-
财政年份:2022
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Biology of Submucosal Gland Stem Cells in the Airway
-
批准号:10649543
-
项目类别:
-
资助金额:$70.18万
-
财政年份:2022
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:10599931
-
项目类别:
-
资助金额:$147.99万
-
财政年份:2021
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10470338
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10677622
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10248531
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10024668
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
National Ferret Resource and Research Center on Lung Disease
-
批准号:8751112
-
项目类别:
-
资助金额:$83.26万
-
财政年份:2014
-
负责人:JOHN F ENGELHARDT
-
依托单位:
National Ferret Resource and Research Center on Lung Disease
-
批准号:9283593
-
项目类别:
-
资助金额:$80.96万
-
财政年份:2014
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:8769764
-
项目类别:
-
资助金额:$152.34万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:9110992
-
项目类别:
-
资助金额:$151.16万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:9312250
-
项目类别:
-
资助金额:$151.16万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:8529523
-
项目类别:
-
资助金额:$123.17万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:8385023
-
项目类别:
-
资助金额:$131.43万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:9043453
-
项目类别:
-
资助金额:$1.36万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8462292
-
项目类别:
-
资助金额:$54.56万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8150246
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8656409
-
项目类别:
-
资助金额:$55.06万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8293174
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: